Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 1, 2011, Pages 123-130

  Seethala, Raja R ^a   Cieply, Kathleen ^a   Leon Barnes, E ^b   Dacic, Sanja ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CELL TRANSFORMATION; CHROMOSOME 17; CHROMOSOME 8; CHROMOSOME ABERRATION; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETICS; HUMAN; MALE; MIDDLE AGED; ONCOGENE MYC; PATHOLOGY; PROTO ONCOGENE; SALIVARY GLAND TUMOR;

ADULT; CARCINOMA, ADENOID CYSTIC; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE DOSAGE; GENES, ERBB-2; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SALIVARY GLAND NEOPLASMS;

EID: 79251629269     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Robin C, Laboulbene A. Memoire sur trois productions morbides non decrites. Compte Rend Soc Biol. 1853; 501: 185-196.
2. Chomette G, Auriol M, Tranbaloc P, Vaillant JM. Adenoid cystic carcinoma of minor salivary glands: analysis of 86 cases: clinico-pathological, histoenzymological and ultrastructural studies. Virchows Arch A Pathol Anat Histol. 1982; 395(3): 289-301.
3. Chummun S, McLean NR, Kelly CG, et al. Adenoid cystic carcinoma of the head and neck. Br J Plast Surg. 2001; 54(6): 476-480.
4. da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, de Almeida OP, Kowalski LP. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol. 2006; 42(2): 139-146.
5. Ellis GL, Auclair PL. Tumors of the Salivary Glands. Washington DC: Armed Forces Institute of Pathology; 1996: 203-216. Atlas of Tumor Pathology, 3rd series, fascicle 17.
6. el-Naggar AK, Huvos AG. Adenoid cystic carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005: 221-222. World Health Organization Classification of Tumours.
7. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands: a study of 61 cases with clinicopathologic correlation. Cancer. 1986; 57(2): 312-319.
8. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer. 1978; 42(1): 265-282.
9. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984; 54(6): 1062-1069.
10. Tauxe WN, McDonald JR, Devine KD. A century of cylindromas: short review and report of 27 adenoid cystic carcinomas arising in the upper respiratory passages. Arch Otolaryngol. 1962; 75: 364-376.
11. Patey DH, Thackray AC. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958; 45(193): 477-487.
12. Cheuk W, Chan JK, Ngan RK. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am I Surg Pathol. 1999; 23(4): 465-472.
13. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007; 3101: 44-57.
14. Rosai J. Current Concepts of Dedifferentiation in Soft Tissue and Bone Sarcomas. San Antonio, TX: International Society of Bone and Soft Tissue Pathology; 2005.
15. Rywlin AM. Chondrosarcoma of bone with "dedifferentiation". Hum Pathol. 1982; 13001: 963-964.
16. Malhotra KP, Agrawal V, Pandey R. High grade transformation in adenoid cystic carcinoma of the parotid: report of a case with cytologic, histologic and immunohistochemical study. Head Neck Pathol. 2009; 3(4): 310-314.
17. Akrish S, Peled M, Ben-lzhak O, Nagler RM. Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis. Oral Oncol. 2009; 45(12): 1044-1050.
18. Moles MA, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(2): 177-180.
19. Chau Y., Hongyo T, Aozasa K, Chan JK. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol. 2001; 32(12): 1403-1407.
20. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 200306(12)0265-1272.
21. Frierson HF Jr, El-Naggar AK, Welsh JB, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am I Pathol. 2002; 161(4): 315-1323.
22. Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007; 13(19): 5745-5755.
23. Yasumatsu R, Kuratomi Y, Nakashima T, Masuda M, Yamamoto T. Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland. Eur Arch Otorhinolaryngol. 2004; 261(10): 526-530.
24. Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am I Surg Pathol. 2007; 31 (11): 1683-1694.
25. Alos L, Carrillo R, Ramos J, et al. High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands clinicopathological, immunohistochemical and flow-cytometric study of three cases. Virchows Arch. 1999; 434(4): 291-299.
26. Simpson RH, Pereira EM, Ribeiro AC, Abdulkadir A, Reis-Filho JS. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology. 2002, 41(31): 250-259.
27. Stanley RJ, Weiland LH, Olsen KD, Pearson BW. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland. Otolaryngol Head Neck Surg. 1988; 98(2): 055-161.
28. Ide F, Mishima K, Saito I. Small foci of high-grade carcinoma cells in adenoid cystic carcinoma represent an incipient phase of dedifferentiation. Histopathology. 2003, 43(6): 604-606.
29. El-Rifai W, Rutherford S, Knuutila S, Frierson HF Jr, Moskaluk CA. Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia. 2001; 3(3)073-178.
30. Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005, 159(1): 89-95.
31. Kasamatsu A, Endo Y, Uzawa K, et al. Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses. Int J Biochem Cell Biol. 2005; 37(9): 1869-1880.
32. Roijer E, Dahlenfors R, Mark J, Stenman G. Observations by chromosome banding, FISH and immunohistochemistry in an adenoid cystic carcinoma with del(17)(p13) as the sole deviation. Virchows Arch. 1997; 430(4): 339-342.
33. Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet. 1990; 44(2)053-167.
34. Lopez-Gines C, Cerda-Nicolas M, Llombart-Bosch A. Cytogenetic findings in a new case of adenoid cystic carcinoma arising in sphenoidal sinus. Cancer Genet Cytogenet. 1994; 75(2): 050-152.
35. Rao PH, Roberts D, Zhao YJ, et al. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008; 14(16): 5181-5187.
36. Vekony H, Ylstra B, Wilting SM, et al. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2007; 13(11): 3133-3139.
37. Rutherford S, Hampton GM, Frierson HF, Moskaluk CA. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest. 2005; 85(9)0076-1085.
38. Rutherford S, Yu Y, Rumpel CA, Frierson HF Jr, Moskaluk CA. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett. 2006; 236(2): 309-317.
39. Stallmach I, Zenklusen P, Komminoth P, et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch. 2002; 440(1): 77-84.
40. Sato K, Ueda Y, Sakurai A, et al. Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma. Virchows Arch. 2006; 448(2): 204-208.
41. Kusafuka K. Expressions of oncogene products in adenoid cystic carcinomas of salivary glands: immunohistochemical study [in Japanese). Kokubyo Gakkai Zasshi. 1991; 58(4): 696-717.
42. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 1997; 57(3): 524-531.
43. Bovee JV, Sakkers RJ, Geirnaerdt MJ, Taminiau AH, Hogendoorn PC. Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma: a case report of a patient with hereditary multiple exostoses. J Clin Pathol. 2002; 55(3): 226-229.
44. van Duin M, van Marion R, Vissers KJ, et al. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet Genome Res. 2007; 118(2-4): 30-137.
45. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007; 9(2): 166-180.
46. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. I Clin Oncol. 2007; 25(1): 118-145.
47. Vance KW, Carreira S, Brosch G, Goding CR. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 2005; 65(6): 2260-2268.
48. Bulavin DV, Demidov ON, Saito S, et al. Amplification of PPMID in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 2002; 31(2): 210-215.